Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
The discovery of an asymptomatic adrenal mass (incidentaloma) during the investigation of an unrelated condition is relatively common. In this study, we report the clinical, radiologic, and endocrine evaluation of 38 patients (22 women and 16 men aged 24 to 84 years) with adrenal incidentaloma (size, 1 to 12 cm). The patients underwent basal and dynamic evaluation of the hypothalamic-pituitary-adrenal (HPA) axis, renin-angiotensin-aldosterone system, and adrenomedullary function. Moreover, computed tomograpy (CT) scan and 131I-6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol(NP-59) and/or 131I-metaiodobenzylguanidine (MIBG) scintigraphy were performed. The endocrine evaluation indicated two cases of pheochromocytoma and four cases of preclinical Cushing's syndrome, three of which underwent surgery with histologic diagnosis of two adrenocortical adenomas and one carcinoma. Low levels of serum dehydroepiandrosterone sulfate (DHEA-S), associated with a markedly increased 17-hydroxyprogesterone (17-OHP) response to a corticotropin (ACTH) test, were found in patients with incidentaloma. On the basis of endocrine and morphologic data, 13 patients underwent surgical treatment: five adrenocortical adenomas (two functioning), two pheochromocytomas, two ganglioneuromas, one cortisol-secreting adrenal carcinoma, one lymphangiomatous cyst, one myelolipoma, and one hemorrhage were found. Careful diagnostic assessment of incidentally discovered adrenal masses must be performed to exclude the presence of malignant and/or functioning lesions and to verify the possibility that patients with incidentaloma have a genetic or acquired deficit of adrenal steroidogenic activity.
Bondanelli
M
M
Department of Endocrinology, University of Ferrara, Italy.
Campo
M
M
Trasforini
G
G
Ambrosio
M R
MR
Zatelli
M C
MC
Franceschetti
P
P
Valentini
A
A
Pansini
R
R
degli Uberti
E C
EC
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000236:Adenoma / Q000737:chemistry* / Q000378:metabolism / Q000503:physiopathology; D000310:Adrenal Gland Neoplasms / Q000737:chemistry* / Q000378:metabolism / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000728:Androgens / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D002395:Catecholamines / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D003480:Cushing Syndrome / Q000378:metabolism / Q000503:physiopathology; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D005938:Glucocorticoids / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D008297:Male; D008875:Middle Aged; D008901:Mineralocorticoids / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D010673:Pheochromocytoma / Q000737:chemistry* / Q000378:metabolism / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000502:physiology; D011863:Radioimmunoassay; D011877:Radionuclide Imaging; D012084:Renin-Angiotensin System / Q000502:physiology; D013739:Testosterone / Q000097:blood; D014057:Tomography, X-Ray Computed
D000728:Androgens; D002395:Catecholamines; D005938:Glucocorticoids; D008901:Mineralocorticoids; D013739:Testosterone; D019314:Dehydroepiandrosterone Sulfate; D019326:17-alpha-Hydroxyprogesterone; D000324:Adrenocorticotropic Hormone